HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters
27277studies shown
Showing 7,825-7,836 of 27,277
Drug study icon
CompletedNCT03854409

A study of Single- and Multiple-doses of Aripiprazole in Adult Subjects With Schizophrenia or Bipolarity type I

Official study title

An Open-label, Single- and Multiple-dose, Pharmacokinetic, Safety, and Tolerability Trial of Aripiprazole Long-acting Injectable Administered in the Deltoid or Gluteal Muscle in Adult Subjects With Schizophrenia or Bipolar I Disorder

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
Bipolarity, SchizophreniaMedication studyAges 18–64
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Drug study icon
Active Not RecruitingNCT06894212

SEP-363856 for schizophrenia

What is this study about?

Researchers are comparing SEP-363856 and placebo to find out how the approaches affect psychotic symptoms in people with schizophrenia.

This study is no longer accepting new participants.

Multiple locations, including Bentonville
SchizophreniaMedication studyAges 18–65
Countries
United States, Japan
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Drug study icon
CompletedNCT04512066

A study of the Efficacy and the Safety of RO6889450 (Ralmitaront) vs Placebo in people with an Acute Exacerbation of Schizophrenia or Schizoaffective Disorder

What is this study about?

This study evaluated the safety and effectiveness of RO6889450 for people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
SchizophreniaMedication studyAges 18–45
Countries
United States, Japan, Russia, + 1 other
Sponsor
Hoffmann-La Roche
Drug study icon
CompletedNCT05593029

A study of the Safety and Efficacy of SEP-363856 in the Treatment of Adults With Major Depressive Disorder

What is this study about?

This study evaluated the safety and effectiveness of SEP-363856 for people with depression.

This study has finished and is no longer accepting participants.

Multiple locations, including Birmingham
DepressionMedication studyAges 18–65
Countries
United States, Canada, Bulgaria, + 4 others
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Behavioral study icon
CompletedNCT06366438

A study of Two Universal Programs for Parents of Teenagers

Official study title

A Randomized Controlled Trial of Two Universal Programs for Parents of Teenagers: ABC (Face-to-face) vs. Parentweb (Online)

This study has finished and is no longer accepting participants.

Multiple locations, including Bromma
Mental healthBehavioural studyAges 13–19
Countries
Sweden
Sponsor
Karolinska Institutet
Drug study icon
CompletedNCT06372210

A study to Assess a Wearable Patch's Functioning to Detect Medication Ingestion

Official study title

An Open-label, Prospective Trial Assessing Positive Detection Accuracy and Detection Latency Measures of the Miniature Ingestible Event Marker Tablet Using the D-Tect Patch in Healthy Subjects and Assessing Detection Latency Measures Using the D-Tect Patch in Subjects With Serious Mental Illness Taking Abilify MyCite Tablet

This study has finished and is no longer accepting participants.

In Garden Grove
Depression, Schizophrenia, ...Medication studyAges 18+
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Drug study icon
CompletedNCT03259555

A study to Assess Brexpiprazole Versus Placebo for Acute manic episodes Associated With Bipolarity type I

What is this study about?

Researchers compared Brexpiprazole and placebo to find out how the approaches affected manic symptoms in people with bipolarity type I during a manic episode.

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
BipolarityMedication studyAges 18–65
Countries
United States, Bulgaria, Poland, + 1 other
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Drug study icon
CompletedNCT03257865

A study to Assess Brexpiprazole Versus Placebo for Acute manic episodes, Associated With Bipolarity type I

What is this study about?

Researchers compared Brexpiprazole and placebo to find out how the approaches affected manic symptoms in people with bipolarity type I during a manic episode.

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
BipolarityMedication studyAges 18–65
Countries
United States, Croatia, Ukraine
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Drug study icon
CompletedNCT07314333

A study to Assess How Centanafadine Interacts With Stimulants in the Body

Official study title

A Phase 1, Single Blind, Parallel-arm Trial to Assess the Potential for Pharmacodynamic Interaction of Centanafadine When Co-administered With Stimulants in Healthy Adults

This study has finished and is no longer accepting participants.

In Salt Lake City
ADHDMedication studyAges 18–55
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.